1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 13 JULY 2015

Cancer Drug News 13 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Atezolizumab Will Be Significant Anti-PD-1 Competitor In 2016
Industry Brief - EU Approval Sought For Arzerra As Maintenance Therapy For Relapsed CLL
Industry Brief - Daratumumab EAP Open To Eligible MM Patients In US
Industry Brief - Imbruvica Gains EU Approval For WM
Industry Brief - Mylan Launches Bexarotene In US
Industry Brief - Dosing Begins In Epizyme's Tazemetostat Five-Arm Phase II Study In r/r NHL
Industry Trend Analysis - Necitumumab Closes In On Approval
Industry Brief - Custirsen Phase III NSCLC Trial Continues Following IDMC Recommendation
Industry Trend Analysis - Iressa's US Return Will Be Further Enhanced By Liquid Biopsy
Industry Trend Analysis - Oncolytics Biotech Will Be Target For Immunotherapy Partnerships
Industry Brief - Blaze's BLZ-100 Gains FDA ODD For Brain Cancer
Industry Brief - FDA Grants Fast Track Designation To Tocagen's Toca 511 And Toca FC
Industry Brief - AstraZeneca/Innate Co-Development Deal For IPH2201 Receives HSR Clearance
Industry Brief - Globavir Exclusively Licenses Oncology Compound To Sorrento

Table Of Contents

Cancer Drug News 13 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.